Logo image
Metabolic profiling of a transgenic Caenorhabditis elegans Alzheimer model
Journal article   Open access   Peer reviewed

Metabolic profiling of a transgenic Caenorhabditis elegans Alzheimer model

R. Van Assche, L. Temmerman, D.A. Dias, B. Boughton, K. Boonen, B.P. Braeckman, L. Schoofs and U. Roessner
Metabolomics, Vol.11, pp.477-486
2015
pdf
Metabolic profiling of a transgenic Caenorhabditis elegans Alzheimer model.pdfDownloadView
Published (Version of Record) Open Access
url
Free to Read *No subscription requiredView

Abstract

Despite decades of research, no early-onset biomarkers are currently available for Alzheimer’s disease, a cureless neurodegenerative disease afflicting millions worldwide. In this study, transgenic Caenorhabditis elegans were used to investigate changes in the metabolome after induced expression of amyloid-β. GC- and LC–MS-based platforms determined a total of 157 differential features. Some of these were identified using in-house (GC–MS) or public libraries (LC–MS), revealing changes in allantoin, cystathionine and tyrosine levels. Since C. elegans is far better suited to metabolomics studies than most other model systems, the accordance of these findings with vertebrate literature is promising and argues for further use of C. elegans as a model of human pathology in the study of AD.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

13 File views/ downloads
32 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
2 Chemistry
2.211 Mass Spectrometry
2.211.990 Metabolomics
Web Of Science research areas
Endocrinology & Metabolism
ESI research areas
Biology & Biochemistry
Logo image